159 related articles for article (PubMed ID: 6272967)
1. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological, and immunopathological studies.
Purtilo DT; Sakamoto K; Saemundsen AK; Sullivan JL; Synnerholm AC; Anvret M; Pritchard J; Sloper C; Sieff C; Pincott J; Pachman L; Rich K; Cruzi F; Cornet JA; Collins R; Barnes N; Knight J; Sandstedt B; Klein G
Cancer Res; 1981 Nov; 41(11 Pt 1):4226-36. PubMed ID: 6272967
[TBL] [Abstract][Full Text] [Related]
2. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization.
Saemundsen AK; Purtilo DT; Sakamoto K; Sullivan JL; Synnerholm AC; Hanto D; Simmons R; Anvret M; Collins R; Klein G
Cancer Res; 1981 Nov; 41(11 Pt 1):4237-42. PubMed ID: 6272968
[TBL] [Abstract][Full Text] [Related]
3. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus.
Hanto DW; Frizzera G; Purtilo DT; Sakamoto K; Sullivan JL; Saemundsen AK; Klein G; Simmons RL; Najarian JS
Cancer Res; 1981 Nov; 41(11 Pt 1):4253-61. PubMed ID: 6272971
[TBL] [Abstract][Full Text] [Related]
4. [Studies on Epstein-Barr virus (EBV) infection and reactivity of peripheral B lymphocytes to EBV in patients with ataxia telangiectasia].
Okano M
Hokkaido Igaku Zasshi; 1986 Jul; 61(4):584-92. PubMed ID: 3019855
[TBL] [Abstract][Full Text] [Related]
5. Cellular immune defects to Epstein-Barr virus-determined antigens in young males.
Masucci MG; Szigeti R; Ernberg I; Masucci G; Klein G; Chessels J; Sieff C; Lie S; Glomstein A; Businco L; Henle W; Henle G; Pearson G; Sakamoto K; Purtilo DT
Cancer Res; 1981 Nov; 41(11 Pt 1):4284-91. PubMed ID: 6171337
[TBL] [Abstract][Full Text] [Related]
6. Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients.
Purtilo DT
AIDS Res; 1986 Dec; 2 Suppl 1():S177-81. PubMed ID: 2435295
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-induced diseases in the X-linked lymphoproliferative syndrome and related disorders.
Purtilo DT
Biomed Pharmacother; 1985; 39(2):52-8. PubMed ID: 2990590
[TBL] [Abstract][Full Text] [Related]
8. [Epstein-Barr-virus-induced lymphoproliferative diseases].
Schuster V; Kreth HW
Monatsschr Kinderheilkd; 1991 Jul; 139(7):396-400. PubMed ID: 1656248
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-associated lymphoproliferative disorders.
Purtilo DT; Strobach RS; Okano M; Davis JR
Lab Invest; 1992 Jul; 67(1):5-23. PubMed ID: 1320711
[TBL] [Abstract][Full Text] [Related]
10. Quantitative Epstein-Barr virus (EBV) serology in lung transplant recipients with primary EBV infection and/or post-transplant lymphoproliferative disease.
Verschuuren E; van der Bij W; de Boer W; Timens W; Middeldorp J; The TH
J Med Virol; 2003 Feb; 69(2):258-66. PubMed ID: 12683416
[TBL] [Abstract][Full Text] [Related]
11. Abnormal anti-Epstein Barr virus antibodies in carriers of the X-linked lymphoproliferative syndrome and in females at risk.
Sakamoto K; Seeley JK; Lindsten T; Sexton J; Yetz J; Ballow M; Purtilo DT
J Immunol; 1982 Feb; 128(2):904-7. PubMed ID: 6274962
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease/lymphoma: clinicopathologic, serologic, and molecular analysis.
Mitarnun W; Suwiwat S; Pradutkanchana J; Saechan V; Ishida T; Takao S; Mori A
Am J Hematol; 2002 May; 70(1):31-8. PubMed ID: 11994979
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus and the X-linked lymphoproliferative syndrome.
Sullivan JL
Adv Pediatr; 1983; 30():365-99. PubMed ID: 6324556
[No Abstract] [Full Text] [Related]
14. Epstein-Barr virus (EBV). VI. Incidence of EBV antibodies in patients with malignant lymphoproliferative diseases.
Pătraşcu IV; Tache M; Stoia R; Berceanu S
Virologie; 1989; 40(1):31-4. PubMed ID: 2549700
[TBL] [Abstract][Full Text] [Related]
15. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation.
Rea D; Fourcade C; Leblond V; Rowe M; Joab I; Edelman L; Bitker MO; Gandjbakhch I; Suberbielle C; Farcet JP
Transplantation; 1994 Aug; 58(3):317-24. PubMed ID: 8053055
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
Liu MT; Yeh CY
Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
[TBL] [Abstract][Full Text] [Related]
17. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
[TBL] [Abstract][Full Text] [Related]
18. Summary: symposium on Epstein-Barr virus-induced lymphoproliferative diseases in immunodeficient patients.
Klein G; Purtilo D
Cancer Res; 1981 Nov; 41(11 Pt 1):4302-4. PubMed ID: 6272974
[No Abstract] [Full Text] [Related]
19. The impact of EBV hybridization in clinical and biological medicine.
Morinet F
Nouv Rev Fr Hematol (1978); 1989; 31(2):155-8. PubMed ID: 2549502
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
